Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-14 · accession 0001870913-23-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-08-16 | 2023-08-14+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $61.35 | -50.0K | 1.20M | -4% | -$3.07M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-15 | S | D | 22,110 | $61.60 | 1,182,620 | I Held by Esjay LLC | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.81 to $62.59, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |
| 2 | Common | Common Stock | 2023-08-14 | S | D | 27,890 | $61.15 | 1,204,730 | I Held by Esjay LLC | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.12 to $62.58, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC. |